MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
UPC Universe Pharmaceuticals
- 0.6370
- +0.0020+0.31%
Close Dec 20 16:00 ET
- 0.6427
- +0.0057+0.89%
Post 19:50 ET
1.34MMarket Cap-0.01P/E (TTM)
0.6429High0.6100Low240.93KVolume0.6400Open0.6350Pre Close150.60KTurnover12.26%Turnover RatioLossP/E (Static)2.10MShares64.800052wk High0.05P/B1.25MFloat Cap0.610052wk Low--Dividend TTM1.96MShs Float1079.1000Historical High--Div YieldTTM5.18%Amplitude0.6100Historical Low0.6250Avg Price1Lot Size
Universe Pharmaceuticals News
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
Universe Pharmaceuticals | F-1: Registration statement for securities of certain foreign private issuers
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | F-3: Registration statement for specified transactions by certain foreign private issuers
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.